Welcome to the Allergy Therapeutics Investor Relations Centre.

"We continue to execute our strategy to create significant value for our shareholders."

Manuel Llobet - CEO
Annual General Meeting 2020 Webcast link

UK dial-in: +44 (0) 203 107 0289 / International dial-in: 0800 028 8438 / Conference ID: 4299121

Annual Report 2020